• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带复合DSG2/DSC2/MYH6突变的轻度肥厚型心肌病患者猝死:对一名顶级跑步运动员进行基因评估后重新审视其表型

Sudden death in mild hypertrophic cardiomyopathy with compound DSG2/DSC2/MYH6 mutations: Revisiting phenotype after genetic assessment in a master runner athlete.

作者信息

Castellana Stefano, Mastroianno Sandra, Palumbo Pietro, Palumbo Orazio, Biagini Tommaso, Leone Maria Pia, De Luca Giovanni, Potenza Domenico Rosario, Amico Cesare Maria, Mazza Tommaso, Russo Aldo, Di Stolfo Giuseppe, Carella Massimo

机构信息

Bioinformatics Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy.

Cardiovascular Department, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy.

出版信息

J Electrocardiol. 2019 Mar-Apr;53:95-99. doi: 10.1016/j.jelectrocard.2019.01.002. Epub 2019 Jan 2.

DOI:10.1016/j.jelectrocard.2019.01.002
PMID:30716529
Abstract

Cardiomyopathies represent a well-known cause of heart failure and sudden death. Although cardiomyopathies are generally categorized in distinct nosographic entities, characterized by single gene-to-disease causal relationships, recently, oligogenic mutations have also been associated to relevant cardiac clinical features. We report the case of a master athlete carrying trigenic mutations in desmoglein-2 (DSG2), desmocollin-2 (DSC2) and heavy chain myosin 6 (MYH6), which determine a mild hypertrophic phenotype associated both to ventricular tachyarrhythmias and atrio-ventricular block. We discuss the differential diagnosis and prognostic approach in patient affected by complex cardiomyopathy phenotype, along with the importance of sport restriction and sudden death prevention.

摘要

心肌病是心力衰竭和猝死的常见原因。尽管心肌病通常被归类为不同的疾病实体,其特征是单一基因与疾病的因果关系,但最近,寡基因突也与相关的心脏临床特征有关。我们报告了一例精英运动员的病例,该运动员在桥粒芯糖蛋白-2(DSG2)、桥粒胶蛋白-2(DSC2)和肌球蛋白重链6(MYH6)中携带三基因突,这些突导致了一种轻度肥厚型表型,与室性快速心律失常和房室传导阻滞有关。我们讨论了复杂心肌病表型患者的鉴别诊断和预后方法,以及运动限制和预防猝死的重要性。

相似文献

1
Sudden death in mild hypertrophic cardiomyopathy with compound DSG2/DSC2/MYH6 mutations: Revisiting phenotype after genetic assessment in a master runner athlete.携带复合DSG2/DSC2/MYH6突变的轻度肥厚型心肌病患者猝死:对一名顶级跑步运动员进行基因评估后重新审视其表型
J Electrocardiol. 2019 Mar-Apr;53:95-99. doi: 10.1016/j.jelectrocard.2019.01.002. Epub 2019 Jan 2.
2
Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy.MYH7相关肥厚型心肌病在心室肥厚发生前出现心室颤动。
Heart Rhythm. 2009 Sep;6(9):1366-9. doi: 10.1016/j.hrthm.2009.04.029. Epub 2009 May 4.
3
Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.肥厚型心肌病、运动员心脏,还是两者皆有:一例肥厚型心肌病消退病例
Circ Cardiovasc Imaging. 2015 Jul;8(7):e003312. doi: 10.1161/CIRCIMAGING.115.003312.
4
Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.日本肥厚型心肌病患者基因突变的预后预测价值
Heart Vessels. 2017 Jun;32(6):700-707. doi: 10.1007/s00380-016-0920-0. Epub 2016 Nov 24.
5
[Hypertrophic cardiomyopathy: never-ending complexity].[肥厚型心肌病:无尽的复杂性]
Rev Esp Cardiol. 2006 Oct;59(10):994-6. doi: 10.1157/13093974.
6
Young and early-onset dilated cardiomyopathy with malignant ventricular arrhythmia and sudden cardiac death induced by the heterozygous LDB3, MYH6, and SYNE1 missense mutations.由杂合 LDB3、MYH6 和 SYNE1 错义突变引起的年轻和早发扩张型心肌病、恶性室性心律失常和心源性猝死。
Ann Noninvasive Electrocardiol. 2021 Jul;26(4):e12840. doi: 10.1111/anec.12840. Epub 2021 May 5.
7
Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.肥厚型心肌病中与肌节突变相关的临床结局:对 7675 个人的荟萃分析。
Clin Res Cardiol. 2018 Jan;107(1):30-41. doi: 10.1007/s00392-017-1155-5. Epub 2017 Aug 24.
8
[Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy].肥厚型心肌病患者的β-肌球蛋白重链基因突变
Rev Esp Cardiol. 2006 Oct;59(10):1008-18. doi: 10.1157/13093977.
9
A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.β肌球蛋白重链基因中的错义突变是肥厚型心肌病患者过早猝死的一个预测指标。
J Sports Med Phys Fitness. 1994 Mar;34(1):1-10.
10
Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.使用质谱DNA阵列和高分辨率熔解技术对肥厚型心肌病进行基因诊断。
Rev Port Cardiol. 2011 Jan;30(1):7-18.

引用本文的文献

1
Cardiomyopathy: pathogenesis and therapeutic interventions.心肌病:发病机制与治疗干预措施
MedComm (2020). 2024 Oct 25;5(11):e772. doi: 10.1002/mco2.772. eCollection 2024 Nov.
2
Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.基于集成机器学习的肥厚型心肌病诊断基因生物标志物预测。
J Int Med Res. 2023 Nov;51(11):3000605231213781. doi: 10.1177/03000605231213781.
3
Significance of α-Myosin Heavy Chain () Variants in Hypoplastic Left Heart Syndrome and Related Cardiovascular Diseases.
α-肌球蛋白重链()变体在左心发育不全综合征及相关心血管疾病中的意义。
J Cardiovasc Dev Dis. 2022 May 3;9(5):144. doi: 10.3390/jcdd9050144.
4
Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing.儿童期起病的肥厚型心肌病基因检测的进一步考量
Front Cardiovasc Med. 2021 Jun 21;8:698078. doi: 10.3389/fcvm.2021.698078. eCollection 2021.
5
Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.生物信息学分析鉴定心力衰竭的候选生物标志物和治疗药物。
BMC Cardiovasc Disord. 2021 Jul 4;21(1):329. doi: 10.1186/s12872-021-02146-8.
6
Bioinformatic analysis of membrane and associated proteins in murine cardiomyocytes and human myocardium.鼠心肌细胞和人心肌中膜和相关蛋白的生物信息学分析。
Sci Data. 2020 Dec 1;7(1):425. doi: 10.1038/s41597-020-00762-1.
7
Identification of candidate genes in ischemic cardiomyopathy by gene expression omnibus database.基于基因表达综合数据库鉴定缺血性心肌病的候选基因。
BMC Cardiovasc Disord. 2020 Jul 6;20(1):320. doi: 10.1186/s12872-020-01596-w.
8
Reevaluating the Mutation Classification in Genetic Studies of Bradycardia Using ACMG/AMP Variant Classification Framework.使用ACMG/AMP变异分类框架重新评估心动过缓基因研究中的突变分类
Int J Genomics. 2020 Feb 25;2020:2415850. doi: 10.1155/2020/2415850. eCollection 2020.
9
ORVAL: a novel platform for the prediction and exploration of disease-causing oligogenic variant combinations.ORVAL:一种用于预测和探索致病寡基因变异组合的新平台。
Nucleic Acids Res. 2019 Jul 2;47(W1):W93-W98. doi: 10.1093/nar/gkz437.